Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 190 | 200 | 182 |
| Revenue growth | -5.0% | 9.9% | |
| Cost of goods sold | 110 | 116 | 41 |
| Gross profit | 80 | 84 | 141 |
| Gross margin | 42.1% | 42.0% | 77.5% |
| Selling, general and administrative | 2,874 | 359 | 601 |
| Research and development | 73 | 19 | 13 |
| EBIT | -2,867 | -294 | -473 |
| EBIT margin | -1508.9% | -147.0% | -259.9% |
| Pre-tax income | -3,505 | -302 | -479 |
| Income taxes | 0 | 0 | 0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -3,505 | -302 | -479 |
| Net margin | -1844.7% | -151.0% | -263.2% |
| |
| Diluted EPS | ($0.34) | ($0.03) | ($0.05) |
| Shares outstanding (diluted) | 10,434 | 9,171 | 9,171 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|